Introduction

Coronary artery fistula embolization radiation dose optimization has become a clinical imperative as transcatheter closure of coronary artery fistulas (CAFs) and coronary pseudoaneurysms migrates from specialist congenital centres into mainstream interventional cardiology practice. These anomalies, though uncommon, demand exceptional fluoroscopic precision: operators must navigate tortuous fistula tracts, deploy microcatheters into diminutive distal vessels, and position coils or vascular plugs with sub-millimetre accuracy under prolonged cine acquisition. The consequence is fluoroscopy time that routinely exceeds 45 minutes and air kerma values that can approach deterministic skin injury thresholds in complex cases.

For interventional cardiologists, radiographers, and cath lab administrators, mastering dose reduction during CAF and pseudoaneurysm embolization is not merely an ALARA aspiration but a procedural necessity. The stochastic risks of ionizing radiation—operator cataracts, thyroid malignancy, and left-sided brain tumours—are amplified by the steep angulations and prolonged exposure characteristic of these cases. For patients, particularly children and young adults with congenital fistulas who may require multiple staged procedures over a lifetime, cumulative dose management is paramount. This article presents a comprehensive, evidence-based fluoroscopy protocol for coronary artery fistula embolization radiation dose optimization, integrating projection selection, exposure parameter modulation, micro-roadmapping guidance, and scatter protection with SATPRO bismuth drapes.

Anatomy and pathophysiology of coronary artery fistulas

Embryological origins and anatomical classification

Coronary artery fistulas arise from persistence of intramyocardial sinusoidal connections that fail to involute during normal embryological development. The majority drain into the right ventricle (40%), right atrium (25%), or pulmonary artery (15%), although left-sided drainage into the left ventricle, left atrium, or coronary sinus occurs in 20% of cases.[1] The Right Coronary Artery is the origin in 55% of cases, the Left Anterior Descending Artery in 35%, and circumflex or bilateral origins in 10%.[2]

The anatomical complexity of CAFs directly influences fluoroscopy demand. Simple fistulas with a single feeding vessel and single drainage site may require only modest cine acquisition. Complex fistulas with multiple feeding arteries, tortuous serpentine courses, or distal plexiform networks demand extensive angiographic mapping, selective catheterization of each branch, and repeated confirmatory runs during coil deployment.[3] Each additional feeding vessel adds approximately 10–15 minutes of fluoroscopy time and 2–4 cine acquisitions, escalating the coronary artery fistula embolization radiation dose disproportionately.

Hemodynamic consequences and intervention thresholds

Small fistulas with a pulmonary-to-systemic flow ratio (Qp:Qs) below 1.2:1 are typically managed conservatively. Intervention is indicated for Qp:Qs above 1.5:1, progressive cardiac enlargement, myocardial ischemia from coronary steal, endarteritis risk, or symptomatic heart failure.[4] The decision to intervene therefore selects for larger, more hemodynamically significant fistulas that inherently require more complex catheter work and greater radiation exposure. Operators must balance the therapeutic imperative against the cumulative dose burden, particularly in pediatric patients who may face repeated interventions as fistulas recur or remodel.

Pseudoaneurysm formation and embolization indications

Pathophysiology of coronary pseudoaneurysm

Coronary pseudoaneurysms represent contained ruptures of the vessel wall in which blood extravasates through a disrupted intimal and medial layer but remains confined by the adventitia or pericardial tissue. Unlike true aneurysms, which involve all three vessel wall layers, pseudoaneurysms lack a true endothelial lining and are prone to progressive expansion, rupture, and thrombus formation.[5] Iatrogenic causes dominate the adult population: PCI-related vessel perforation, guidewire exit, balloon over-dilation, or stent malapposition. Spontaneous pseudoaneurysms may complicate Kawasaki disease, Takayasu arteritis, or connective tissue disorders.

The fluoroscopic challenge of pseudoaneurysm embolization lies in defining the neck. A wide-necked pseudoaneurysm (>4 mm or neck-to-dome ratio >0.5) requires adjunctive techniques—balloon remodelling, stent-assisted coiling, or flow-diverter deployment—that add considerable fluoroscopy time.[6] Microcatheter navigation into the pseudoaneurysm sac, often against flow and through tortuous proximal segments, demands high-resolution cine acquisition at steep angles to confirm wire stability before coil delivery.

Embolization devices and procedural workflow

Contemporary CAF and pseudoaneurysm embolization employs a spectrum of occlusive devices. Pushable fibered coils remain the workhorse for small distal fistulas and narrow-necked pseudoaneurysms, offering predictable deployment and thrombogenicity. Detachable coils provide controlled release and repositioning capability in critical locations adjacent to normal coronary branches. Vascular plugs (Amplatzer Vascular Plug series) excel in high-flow fistulas with large diameters, delivering immediate flow cessation with a single device.[7]

Each device class imposes distinct fluoroscopy demands. Coil embolization requires repeated "roadmap" confirmations after each coil to assess residual flow, with microcatheter repositioning for dense packing. Vascular plug deployment demands precise sizing angiography—typically biplane or two orthogonal projections—and careful sheath stability monitoring during device release. The cumulative effect is that coronary artery fistula embolization radiation dose often exceeds that of standard three-vessel coronary angiography by a factor of two to four.

Projection optimization for dose reduction

Straight AP and shallow angles

The single most effective strategy for reducing coronary artery fistula embolization radiation dose is projection optimization. The X-ray beam path through the thorax is shortest in the straight anteroposterior (AP, 0°) projection, minimizing tissue attenuation and scatter generation. For the majority of CAF embolization procedures, AP or shallow cranial/caudal angulation (≤20°) provides adequate visualization of the fistula tract while reducing entrance skin dose by 25–35% compared with steep oblique views.[8]

During the initial diagnostic phase—selective coronary angiography to define fistula origin, course, and drainage—standard working angles (RAO 30°/cranial 30°, LAO 45°/cranial 20°) are necessary to separate overlapping vessels and define the three-dimensional trajectory. However, once the decision to embolize is made and the microcatheter is engaged, operators should default to AP or shallow RAO (10–15°) for wire and device manipulation. These neutral angles maintain sufficient spatial information while cutting beam attenuation significantly. Steep LAO (>40°) and cranial/caudal angulation (>30°) should be reserved for two specific moments: (1) confirming microcatheter tip position in complex tortuosity, and (2) final angiographic assessment after device deployment.[9]

Patient-specific projection planning

Pre-procedural cardiac CT angiography has transformed projection planning for CAF embolization. Three-dimensional volume-rendered reconstructions allow operators to identify the optimal working angle that profiles the fistula perpendicular to the X-ray beam before the patient enters the cath lab. This "virtual angiography" approach eliminates the trial-and-error C-arm rotation that characterizes conventional fistula cases, reducing both fluoroscopy time and the number of diagnostic cine runs.[10] In centres without pre-procedural CT, biplane angiography offers an alternative: simultaneous acquisition in two orthogonal planes halves the number of cine runs required for anatomical definition.

Exposure parameters and pulsed fluoroscopy

Adult exposure settings

Standard adult cardiac catheterization protocols use continuous fluoroscopy at 15–30 frames per second (fps), with cine acquisition at 15 fps. For CAF and pseudoaneurysm embolization, this default is excessive. The protocol recommends pulsed fluoroscopy at 3.75–7.5 fps for all non-critical phases of the procedure: microcatheter advancement, wire exchanges, and coil positioning between confirmatory angiograms. At 3.75 fps, temporal resolution remains adequate for device visualization while reducing dose rate by 50–75% compared with 15 fps continuous mode.[11]

For cine acquisition, the standard 70–85 kV and 50–180 mA range should be modulated based on patient body habitus. In non-obese adults (BMI <30), 70–85 kV with 50–180 mA provides diagnostic image quality for coronary fistula angiography. In obese patients (BMI >35), the automatic exposure control (AEC) system drives kV upward to 90–115 kV and mA to 250–600 mA. While AEC is necessary to penetrate adipose tissue, operators can mitigate the dose penalty by activating copper spectral filtration (0.3–0.9 mm Cu) to harden the beam and reduce low-energy scatter.[12]

Obesity-specific protocols

Obese patients undergoing CAF embolization present a dual challenge: increased beam attenuation and elevated scatter generation. The AEC-driven increase in kV and mA raises operator exposure significantly, particularly to the left side of the body during LAO projections. The protocol mandates SATPRO bismuth scatter drapes placed over the patient's torso and upper abdomen during all obese cases. These drapes attenuate scattered X-rays at the source, reducing operator hand dose by up to 60% and body dose by 40%.[13]

Additionally, obese patients should have the detector positioned as close to the chest wall as anatomically possible. Inverse square law physics dictates that every 10 cm of increased source-to-image distance (SID) requires a 44% increase in exposure to maintain signal-to-noise ratio. Positioning the detector within 15 cm of the skin surface is a zero-cost dose reduction strategy that is particularly impactful during prolonged embolization procedures.

Micro-roadmapping and overlay guidance

Stored fluoroscopy loops

The use of micro-roadmapping is transformative for reducing coronary artery fistula embolization radiation dose. By storing a reference fluoroscopy loop from an initial angiographic run, operators can navigate microcatheters, wires, and delivery sheaths against a static anatomical map, eliminating multiple subsequent cine acquisitions. Roadmapping is particularly valuable during the critical phase of microcatheter engagement into the fistula ostium, where repeated contrast injections would otherwise be required to confirm position.[14]

Modern angiography systems offer two roadmapping modes relevant to CAF embolization. Standard roadmap subtracts a mask image from live fluoroscopy, creating a contrast-filled vessel silhouette against a dark background. Motion-compensated roadmap uses edge-detection algorithms to adjust for patient motion and respiratory drift, maintaining registration accuracy during prolonged procedures. For CAF cases, where respiratory motion of the heart can displace the fistula ostium by 5–10 mm, motion-compensated roadmapping reduces the need for repeat mask acquisitions and contrast reinjection.[15]

Three-dimensional rotational angiography

Three-dimensional rotational angiography (3D-RA) provides a volumetric dataset from a single 200° C-arm rotation, generating multiplanar reconstructions that can be overlaid onto live fluoroscopy. For complex fistulas with multiple feeding branches, 3D-RA eliminates the need for repeated two-dimensional cine runs to define branch anatomy. The technique does require a higher initial radiation dose (typically 0.5–1.5 mGy for a rotational run), but this is offset by the elimination of 3–5 conventional cine acquisitions that would otherwise be necessary.[16] In experienced centres, 3D-RA-guided CAF embolization reduces total procedural air kerma by 20–30% compared with conventional angiography.

Scatter mitigation with SATPRO protection

Source-based scatter attenuation

Scatter radiation—not the primary beam—poses the greatest occupational hazard during CAF and pseudoaneurysm embolization. The X-ray beam interacts with the thoracic skeleton, prosthetic devices, and contrast-filled cardiac chambers, generating a 360° scatter field. The operator, positioned on the patient's right side for femoral or radial access, receives the highest scatter dose when the tube is in LAO projection, which is frequently required to profile tortuous fistula courses.[17]

SATPRO lead-free bismuth drapes are designed to attenuate this scatter at its origin. Draped over the patient's torso, chest wall, and upper abdomen, these flexible shields contain bismuth oxide particles suspended in a polymer matrix, providing attenuation equivalent to 0.5 mm lead without the weight or toxicity. For CAF embolization, the drape should cover:

• The entire chest wall from clavicles to xiphoid process.
• The upper abdomen, where lateral scatter from the diaphragm and liver is significant during cranial angulation.
• The groin or radial access site, to protect against backscatter from the vascular entry region.

Clinical phantom studies demonstrate that SATPRO drapes reduce operator hand dose by 55–65% during prolonged structural procedures and lower patient entrance dose by 15–20% through backscatter reduction.[18]

Shielding configuration for CAF and pseudoaneurysm procedures

For distal coronary fistula embolization via femoral access, the operator stands on the patient's right side, exposed to left-sided scatter. A SATPRO drape suspended from an overhead boom should cover the patient's left lateral chest wall and upper abdomen. An additional sterile drape placed over the right lower chest wall protects the assistant and anaesthesia team. For proximal pseudoaneurysm coiling, where steep cranial angulation is frequently required, a full-torso SATPRO drape combined with a ceiling-suspended lead acrylic shield positioned between the operator and the patient creates a multi-layered defence.

The protocol emphasizes that personal protective equipment—lead aprons (minimum 0.5 mm lead equivalent), thyroid shields, and lead glasses—remains mandatory regardless of patient draping. SATPRO reduces the scatter load, but does not eliminate it. In high-volume centres performing more than 50 complex embolization procedures annually, the combination of SATPRO draping, lead acrylic shields, and dosimetry feedback has been shown to keep operator whole-body dose below 2 mSv per year.[19]

Pediatric protocol adaptations

Grid removal and spectral optimization

Pediatric CAF embolization demands fundamentally different dose parameters from adult practice. Children under 20 kg (or body thickness <15 cm) should have the anti-scatter grid removed before the procedure begins. This single intervention reduces skin entrance dose by 30–50% without compromising image quality in small thoraces where scatter generation is minimal.[20] For neonates and infants, grid removal is non-negotiable: the radiation dose penalty of grid use in patients under 10 kg exceeds any marginal improvement in contrast-to-noise ratio.

Spectral filtration should be minimized in pediatric patients. While copper filtration (0.3–0.9 mm Cu) is beneficial in adults to harden the beam, pediatric protocols should use aluminium filtration only to preserve low-contrast resolution in small vessels. Tube potential should be reduced to 50–65 kV with 10–40 mA, and pulse rates stepped down to 3.75 fps for all phases except critical device deployment.[21]

Micro-collimation and field size

Tight micro-collimation to the cardiac silhouette and fistula tract only is the most impactful pediatric dose reduction strategy. The X-ray field should never exceed the region of diagnostic interest by more than 2 cm in any dimension. In practice, this means collimating to a 10–12 cm field for neonatal cases and a 15–18 cm field for school-age children. Every centimetre of field size reduction decreases dose area product (P_KA) by approximately 8–12%.[22]

Children have 2–3× higher radiation sensitivity per unit dose than adults, and cumulative lifetime risk from a single high-exposure procedure is significant. For pediatric patients with congenital CAFs who may require staged embolization across childhood and adolescence, meticulous dose documentation and cumulative tracking are essential. Departments should maintain a dedicated pediatric interventional cardiology dose registry, with alert thresholds triggered when a patient's cumulative air kerma exceeds 1 Gy.[23]

Dose monitoring and quality assurance

Real-time dose feedback

Systematic dose monitoring is essential for any programme performing CAF and pseudoaneurysm embolization. Every case should generate a dose report including: total fluoroscopy time, number and duration of cine runs, cumulative air kerma (K_a,r), kerma-area product (P_KA), and peak skin dose estimate. These data should be reviewed at weekly multidisciplinary meetings, with outliers (>5 Gy air kerma) triggering mandatory case review.[24]

Operator feedback loops are equally important. Real-time dose displays, positioned in the operator's direct line of sight, have been shown to reduce exposure by 15–25% through behavioural modification alone.[25] Programmes that combine dose monitoring, feedback, and standardized protocols report sustained reductions in median procedural dose of 30–40% over 12 months. For CAF embolization specifically, benchmarking against diagnostic reference levels (DRLs) published by the International Commission on Radiological Protection provides an objective quality metric.

Quality assurance benchmarks

The following diagnostic reference levels are proposed for CAF and pseudoaneurysm embolization based on current literature and institutional best practice:

Conclusion

Coronary artery fistula embolization and coronary pseudoaneurysm closure represent some of the most fluoroscopy-intensive interventional procedures in the cardiac catheterization laboratory. The rarity of these anomalies, combined with the technical complexity of microcatheter navigation, multi-branch fistula mapping, and precise coil or plug deployment, drives radiation exposure well above standard diagnostic angiography levels. For operators, the cumulative stochastic risks of cataracts, thyroid malignancy, and brain tumours are amplified by the steep angulations and prolonged cine acquisition that these cases demand. For patients—particularly children with congenital fistulas who face potential repeated interventions across a lifetime—cumulative skin dose management is a critical safety priority.

The protocol presented here integrates four pillars of dose reduction: projection optimization (straight AP and shallow angles for the majority of device manipulation), exposure parameter modulation (pulsed fluoroscopy at 3.75–7.5 fps, spectral filtration, and AEC-aware kV/mA selection), micro-roadmapping and 3D overlay guidance (eliminating redundant cine runs through stored reference loops and rotational angiography), and scatter mitigation (SATPRO lead-free bismuth drapes, micro-collimation, and strategic shielding). Together, these measures can reduce cumulative air kerma by 40–50% compared with conventional embolization workflows, without compromising procedural precision or safety.

For adult patients, the emphasis should remain on pulsed fluoroscopy, pre-procedural CT-based projection planning, and heavy reliance on roadmapping to minimize cine runs. In obese populations, AEC-driven protocols with copper filtration and strategic SATPRO draping over the torso are essential to manage elevated scatter. For pediatric patients, the principles of grid removal, spectral optimization, micro-collimation, and cumulative dose tracking are non-negotiable. Institutions that adopt structured dose-monitoring, operator feedback loops, and standardized scatter-protection protocols will see the greatest reductions in long-term stochastic risk for both patients and catheterization laboratory staff.

Ultimately, radiation safety in coronary artery fistula and pseudoaneurysm embolization is not achieved by any single technique, but by the systematic application of ALARA principles at every step—from pre-procedural planning through final device release. The investment in dose optimization pays dividends not only in reduced cancer risk and cataract incidence but in improved procedural efficiency, shorter recovery times, and the confidence that every intervention has been performed with the utmost regard for patient and operator welfare.

Further reading

References